Results
281
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
281 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RADA | US$9.87 | -2.4% | 5.0% | US$490.9m | US$14.00 | PE85x | E83.7% | n/a | ||
SCX | US$16.18 | 0.1% | 52.4% | US$118.7m | n/a | PE9.7x | n/a | 0% | ||
DCI | US$68.02 | -5.4% | 3.7% | US$8.1b | US$75.83 | PE19.3x | E6.7% | 1.6% | ||
ORN | US$7.68 | -8.9% | 56.4% | US$298.8m | US$11.33 | PS0.4x | E124.5% | n/a | ||
ESE | US$135.31 | -3.6% | 16.6% | US$3.5b | US$147.75 | PE34.3x | E16.5% | 0.2% | ||
TNC | US$80.29 | -5.4% | -12.9% | US$1.5b | US$128.00 | PE14x | E7.6% | 1.5% | ||
CLWT New | US$1.50 | 4.2% | -11.8% | US$11.6m | n/a | PE5.4x | n/a | 8.9% | ||
PCAR | US$105.32 | -6.2% | 8.1% | US$55.2b | US$115.51 | PE11.7x | E-0.1% | 4.3% | ||
PLPC | US$124.19 | -6.7% | -8.5% | US$608.2m | n/a | PE18.4x | n/a | 0.6% | ||
NPWR | US$9.60 | -3.1% | -9.7% | US$2.1b | US$17.67 | PE94.6x | S138.4% | n/a | ||
FLS | US$58.06 | -5.2% | 40.5% | US$7.6b | US$68.80 | PE28.5x | E25.2% | 1.4% | ||
MTRX | US$12.16 | -8.7% | 20.5% | US$335.1m | US$17.00 | PS0.5x | E167.9% | n/a | ||
BLBD | US$39.37 | -11.3% | 51.9% | US$1.3b | US$59.64 | PE12x | E15.0% | n/a | ||
BXC | US$106.77 | -9.1% | -6.0% | US$894.8m | US$135.50 | PE30.1x | E23.6% | n/a | ||
LMB | US$89.76 | -3.7% | 101.0% | US$1.0b | US$107.00 | PE38.5x | E19.1% | n/a | ||
GWW | US$1,092.96 | -4.1% | 32.0% | US$53.2b | US$1,082.08 | PE29.1x | E8.0% | 0.8% | ||
ULBI | US$7.29 | -6.8% | 3.1% | US$121.2m | US$14.00 | PE13.5x | E43.8% | n/a | ||
MYRG | US$153.30 | -8.0% | 5.7% | US$2.5b | US$181.33 | PE64.4x | E67.1% | n/a | ||
CVR | US$16.26 | -4.9% | -2.5% | US$15.7m | n/a | PS0.5x | n/a | 0.7% | ||
GHM | US$40.76 | -10.4% | 114.3% | US$443.9m | US$49.83 | PE57.3x | E34.1% | 0% | ||
OFLX | US$42.69 | -5.6% | -47.0% | US$430.9m | n/a | PE23.6x | n/a | 3.2% | ||
EME | US$465.82 | -3.9% | 115.6% | US$21.4b | US$540.00 | PE23.1x | E8.9% | 0.2% | ||
NPK | US$93.45 | -0.1% | 14.6% | US$663.5m | n/a | PE19.6x | n/a | 4.8% | ||
BYRN | US$29.56 | 12.9% | 329.0% | US$665.2m | US$25.63 | PE290.4x | E35.4% | n/a |